Evidence map›Paper›PMID 30093400›Full record

ArticleHaematologica2018

Optimizing diagnostic biomarkers of iron deficiency anemia in community-dwelling Indian women and preschool children.

Giridhar Kanuri, Deepti Chichula, Ritica Sawhney, Kevin Kuriakose, Sherwin De'Souza, Faye Pais, Karthika Arumugam, Arun S Shet

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Iron Therapeutics in Women's Health: Past, Present, and Future.Pharmaceuticals (Basel, Switzerland) · 2020
    Review
  6. New diagnostic tools for delineating iron status.Hematology. American Society of Hematology. Education Program · 2019
    Article
  7. Article
  8. Assessment of iron deficiency.Haematologica · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Giridhar KanuriWellcome Trust-DBT Hematology Research Unit, St. Johns Research Institute, Bangalore, Karnataka, India.
Deepti ChichulaWellcome Trust-DBT Hematology Research Unit, St. Johns Research Institute, Bangalore, Karnataka, India.
Ritica SawhneyWellcome Trust-DBT Hematology Research Unit, St. Johns Research Institute, Bangalore, Karnataka, India.
Kevin KuriakoseWellcome Trust-DBT Hematology Research Unit, St. Johns Research Institute, Bangalore, Karnataka, India.
Sherwin De'SouzaWellcome Trust-DBT Hematology Research Unit, St. Johns Research Institute, Bangalore, Karnataka, India.
Faye PaisWellcome Trust-DBT Hematology Research Unit, St. Johns Research Institute, Bangalore, Karnataka, India.
Karthika ArumugamWellcome Trust-DBT Hematology Research Unit, St. Johns Research Institute, Bangalore, Karnataka, India.
Arun S ShetWellcome Trust-DBT Hematology Research Unit, St. Johns Research Institute, Bangalore, Karnataka, India arun.shet@nih.gov.
Koneru Lakshmaiah Education Foundation · INNational Heart Lung and Blood Institute · US

Funding

Wellcome Trust
6 · The paper itself

Abstract

The detection of iron deficiency anemia is challenged by the paucity of diagnostic tests demonstrating high sensitivity and specificity. Using two biomarkers, zinc-protoporphyrin/heme and hepcidin, we established the diagnostic cut-off values for iron deficiency anemia in preschool children and women. We randomly selected non-anemic individuals (n=190; women=90, children=100) and individuals with iron deficiency anemia (n=200; women=100, children=100) from a preexisting cohort of healthy preschool children and their mothers. The diagnostic performance of these biomarkers was estimated by analyzing receiver operating characteristic curves. Diagnostic cut-offs with a high predictive value for iron deficiency anemia were selected. Median zinc-protoporphyrin/heme and hepcidin values in non-anemic children were 49 μmol/mol heme and 42 ng/mL, respectively, and in non-anemic women these values were 66 μmol/mol heme and 17.7ng/mL, respectively. Children and women with iron deficiency anemia had higher zinc-protoporphyrin/heme ratios (children=151 μmol/mol heme and women=155 μmol/mol heme) and lower hepcidin levels (children=1.2ng/mL and women=0.6ng/mL). A zinc-protoporphyrin/heme ratio cut-off >90 μmole/mole heme in children and >107 μmole/mole heme in women was associated with a high diagnostic likelihood for iron deficiency anemia (children, likelihood ratio=20.2: women, likelihood ratio=10.8). Hepcidin cut-off values of ≤6.8ng/mL in children and ≤4.5ng/mL in women were associated with a high diagnostic likelihood for iron deficiency anemia (children, likelihood ratio=14.3: women, likelihood ratio=16.2). The reference ranges and cut-off values identified in this study provide clinicians with guidance for applying these tests to detect iron deficiency anemia. Erythrocyte zinc-protoporphyrin/heme ratio is a valid point-of-care biomarker to diagnose iron deficiency anemia.

Indexed as

AdultAnemia, Iron-DeficiencyBiomarkersChild, PreschoolCohort StudiesFemaleHemeHepcidinsHumansIndependent LivingIndiaMaleProtoporphyrinsReference ValuesROC CurveYoung AdultBiomarkersHemeHepcidinsProtoporphyrins

Identifiers

PMID30093400
PMCPMC6269316
OpenAlexW2885197038

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.